Figure 1.
Observed viral load decrease (left) and CD4 increase (right) after treatment initiation in the three PI groups: lopinavir (top), indinavir (middle) and nelfinavir (bottom)
Observed viral load decrease (left) and CD4 increase (right) after treatment initiation in the three PI groups: lopinavir (top), indinavir (middle) and nelfinavir (bottom)